滚动资讯
FierceBiotechHumacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implantFierceBiotechWith $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’Endpoints NewsPost-Hoc: Why FDA Commissioner Marty Makary was oustedFierceBiotech复星花6000万美元购买AriBio三期阿尔茨海默症资产选择权BioPharma DiveAssertio接受新的收购报价；AI生物科技公司Isomorphic融资20亿美元LabCorpLabcorp stock (US50540R4092): Enhances Partnership with Epic for Lab Services - AD HOC NEWSEli LillyEli Lilly shows sustained weight loss in new pill study - medwatch.comCatalentElpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing - Contract PharmaEndpoints News加拉帕戈斯转型为湖畔生物疗法的背后FierceBiotechValneva因旅游疫苗市场"不利趋势"将裁减多达15%员工PharmaVoice印度制药业正向全球进军，但能否追上中国？PharmaVoiceFDA推动实时临床试验可能有利于大型制药公司

资讯库

最新 最旧
总数 10990
页码 240 / 611
搜索 --